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Despite it has been reported that several loci are involved in Hirschsprung’s disease, the molecular basis of the
disease remains yet essentially unknown. The study of collective properties of modules of functionally-related genes
provides an efficient and sensitive statistical framework that can overcome sample size limitations in the study of
rare diseases. Here, we present the extension of a previous study of a Spanish series of HSCR trios to an international
cohort of 162 HSCR trios to validate the generality of the underlying functional basis of the Hirschsprung’s disease
mechanisms previously found. The Pathway-Based Analysis (PBA) confirms a strong association of gene ontology (GO)
modules related to signal transduction and its regulation, enteric nervous system (ENS) formation and other processes
related to the disease. In addition, network analysis recovers sub-networks significantly associated to the disease,
which contain genes related to the same functionalities, thus providing an independent validation of these
findings. The functional profiles of association obtained for patients populations from different countries were
compared to each other. While gene associations were different at each series, the main functional associations
were identical in all the five populations. These observations would also explain the reported low reproducibility
of associations of individual disease genes across populations.Background
Unlike a minority of Mendelian traits, most human dis-
eases have complex, multifactorial inheritance where
the causation resides in small allelic differences in many
genes occurring in a complex manner. For these pheno-
types, onset, penetrance, recurrence risk, etc., are fea-
tures not dependent on one single gene, but are rather
emergent properties of the ensemble of genotypes at
many loci [1]. A representative example of this kind of
trait is Hirschsprung’s disease (HSCR, OMIM 142623),
a neurocristopathy characterized by the absence of
intramural ganglion cells in the myenteric and sub-
mucosal plexuses along a variable portion of the distal
intestine. Based on the length of the aganglionic region,
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reproduction in any medium, provided the oraganglionosis up to the upper sigmoid colon, 80% of
cases), long-segment (L-HSCR: aganglionosis up to the
splenic flexure and beyond, 17% of cases) and total
colonic aganglionosis forms (TCA, 3% of cases). The
most widely accepted etiopathogenetic hypothesis for
HSCR is based on a defect of craniocaudal migration of
neuroblasts originating from the neural crest that,
under normal circumstances, reach the small intestine
in the week 7 of gestation and the rectum in the 12th
week [2,3]. HSCR constitutes a complex pathology with
non-Mendelian inheritance, sex-dependent penetrance,
variable expression and suggestive of the involvement of
one or more gene(s) with low penetrance [2,3]. With a
relative risk as high as 200, HSCR can be considered an
excellent model to study common multifactorial diseases.
The major HSCR predisposing event is the presence of
a haplotype at the RET proto-oncogene [4,5] (OMIM
164761, 10q.11) which comprises a SNP lying in an en-
hancer element of the intron 1 [2,3,6-8]. To date, several
HSCR-associated regions, such as 10q11 [9-12], 13q22
[10], 9q31 [9,13], 3p21 [11,14], 19q12 [11], 16q23 [10],tral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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described. Moreover, in some cases, the HSCR gene within
the associated region has been already identified, as it is
the case of RET at 10q11, EDNRB (OMIM 131244) at
13q22, or NRG1 (OMIM 142445) within 8p12 [16]. In
addition, a very recent study based on pathways and
networks analyses of a Spanish series of HSCR patients,
described associations of four new loci (RASGEF1A,
IQGAP2, DLC1 and CHRNA7) to the disease [17].
Conventional gene-based association tests present
obvious limitations, especially in the context of rare
diseases, where the recruitment of large cohorts of
patients is extremely difficult. However, Pathway-based
analysis (PBA) strategies [18-20], which allows for the
detection of modules of functionally-related genes asso-
ciated to the disease, have already been successfully
applied to the study of a number of diseases [17,21-23].
The recent description of HSCR-associated functional
modules in Spanish population [17] constitutes an excel-
lent example of how a PBA strategy can be successfully
applied to define the molecular basis of the mechanism of
the disease. Here we have extended such approach to
different populations of the International Consortium for
Hirschsprung disease (ICHSCR) which have provided
samples from France, Italy, the Netherlands and the USA.
The extended study allowed us to conclude that functionalFigure 1 Schema of the analysis strategy used to validate the finding
information about the four additional populations present in the conmodules related to signal transduction and its regulation,
neurogenesis and the Ras pathway are common to all the
populations in spite of the fact that the most associated
genes in each population were different. Moreover,
Network analysis recovers sub-networks significantly
associated to the disease and populated by genes with
the same functionalities, thus confirming the findings
of the PBA analysis by an independent methodology.
Methods
General analysis strategy
Based in the recent study which identified four new loci
associated to HSCR [17] as a starting point, we aimed to
validate whether the discoveries made were specific for
the analysed population or, on the contrary, were common
mechanisms shared by other populations. Figure 1 shows
the strategy followed in this study: our initial hypothesis
was that disease genes would probably be population
specific whereas functional modules would be universal.
Samples and SNP genotyping
We have conducted a genome wide genotyping of a
multinational cohort of 162 trios of sporadic short-
segment Hirschsprung’s patients recruited in the context
of the ongoing initiative of the ICHSCR. Genotyping was
carried out using the Affymetrix 500 k chip (composeds in the Spanish population [17] with the available scattered
sortium.
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Given that not all the trios were simultaneously genotyped
with both chips yet (only 26 of them), we considered two
independent measurements, one for each chip (Sty and
Nsp, with 97 and 91 trios, respectively), of the samples
analyzed. Quality controls were as follows: SNPs miss-
ing in more than 20% of the samples in the calling
process, SNPs with MAF < 0.5%, with Mendelian errors
or not in Hardy-Weinberg equilibrium (in unaffected
samples; p-value < 10-5) and samples with more than 5%
of the SNPs missing were discarded. Finally, incomplete
families (trios) were also discarded. Additional file 1:
Table S1 summarizes the effects of the different steps of
the quality control.
Pathway-based analysis
We conducted a Transmission Disequilibrium Test (TDT)
association analysis as implemented in the PLINK [24]
software for the different sets of trios analyzed (see
Figure 1).
The SNPs were ranked according to their p-values
obtained in the TDT test and then a PBA test [18], as im-
plemented in the GESBAP [25] module of the Babelomics
[26] software, was conducted. PBA seeks for gene sets
(GO terms in this study) associated to low p-values. This
association is found significant when a number of genes of
the GO term, larger than expected by chance, simultan-
eously display low (although not necessarily significant)
individual p-values [18]. Given that only genes can be
related to GO terms, PBA tests use only SNPs mapping
on genes, or in the close neighborhood, here defined as
500 bps up-and downstream of the gene limits. When
multiple SNPs map onto the same gene, the SNP with
lowest (most significant) p-value is retained. In this way a
list of genes ranked by the best of the p-values of all the
SNPs mapping onto them is constructed. Then, GO terms
significantly overrepresented among the genes associated
to low p-values are found upon the application of a logistic
regression. GO terms are declared significantly associated
to HSCR when a number of its genes, larger than expected
purely by chance, display a low p-value (i.e., are on the top
of the list ranked by significance). To control the numberTable 1 Available trios for any of the chips distributed
among the five country populations analyzed
Chip France Italy USA Netherlands Total
Nsp 15 20 25 37 97
Sty 16 18 25 32 91
Nsp + Sty 5 1 9 11 26
Total trios 26 37 41 58 162
First and second rows refer to the trios genotyped with each specific chip
(Nsp or Sty). Third file contains the trios simultaneously genotyped with both
chips (Nsp + Sty). Forth row is the total number of trios used in the study for
each population.of false positives due to multiple-testing effects, only GO
terms with a FDR-adjusted [27] p-value < 0.05 are declared
significant. The adjustment process takes into account
that four populations and two chips have been tested,
so all the individual tests were considered here. This is
a widely accepted method for correcting p-values that
account for multiple testing by controlling the rate of
false discoveries. By default the GESBAP software only
analyses GO terms between levels 3 and 13 of the GO
hierarchy and exclude GO terms with more than 600
genes or with less than 5 genes. In this way GO terms
which are either too specific or too unspecific, and only
contribute to the decrease of the statistical power of
the test, are avoided.Network analysis
Like in the PBA approach, a list of genes ranked from
low to high p-values is explored in order to discover
subnets with connectivity values higher than expected
by chance. Briefly, the N (10 in this case) most signifi-
cant genes are mapped onto the interactome and the
minimum network connecting them is obtained. The
connectivity of such sub-network is calculated as the
average of all the individual connectivity values of all
the connected genes. The connectivity parameter ac-
counts for the number of partners of direct interaction
that a particular node has. An empirical distribution of
the random expectation of this parameter can be ob-
tained by repeatedly sampling random sets of N genes
from the complete genome and calculating the average
connectivity of their corresponding minimum con-
necting trees. Thus, the real value obtained for the N
most associated genes can be contrasted with respect
to its random empirical expectation. If the connectiv-
ity is not significantly higher than its random expect-
ation we repeat the procedure for the N + 1 most
significant genes. The procedure is repeated until a
sub-network of significant connectivity is found or a
value of N too high is reached (200 in this case). This
procedure [28] is a generalization of the network ana-
lysis methodology applied to the study of networks
contained in gene expression signatures [29,30]. An
implementation of the procedure can be found in the
Babelomics package [26].ENCODE information for extra Genic SNPs
Extra genic SNPs have been used to find extra support
for the functionalities found as associated to HSCR. We
have used the HaploReg [31] tool to retrieve the relevant
information from the ENCODE project [32] correspond-
ing to the chromosomal regions in which significant
extra-genic SNPs map.
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Validation of the known HSCR-associated functionalities
by PBA of the available chips from the different country
populations
As described in the Methods section (see Figure 1), we
used the GO terms already described as part of the
disease mechanism in the Spanish population [17] as
the initial hypothesis that should be validated using all
the available information in the four populations of the
consortium. Then, an independent PBA was carried out
for each chip in each population. The p-values of the
SNPs in each chip/population were obtained by means
of a TDT test, as implemented in the PLINK package.
Such p-values were introduced in the PBA section of
the Babelomics package to complete the PBA test and
obtain lists of GO terms significantly associated to each
condition tested.
Results are summarized in Table 2. All the GO terms
previously proposed as components of the disease mech-
anism were validated in the four populations in one or
both chips, with the exception of enzyme linked receptor
protein signaling pathway (GO:0007167), which seems
to be an aspect of signaling peculiar of the Spanish
population. In addition to the proposed GO terms other
new terms have been included in Table 2 because of their
consistent significance across the populations analyzed
and also because of their relationship to ENS formation.Table 2 GO modules significantly associated to HSCR in the d
separately
GO ID Initial hypothesis
Signaling GO:0051056 Regulation of small GTPase mediated signa
GO:0046578 Regulation of Ras protein signal transducti
GO:0007265 Ras protein signal transduction
GO:0007264 Small GTPase mediated signal transduc
GO:0035023 Regulation of Rho protein signal transduct
GO:0009966 Regulation of signal transduction
GO:0007167 Enzyme linked receptor protein signalin
GO:0007268 Synaptic transmission




GO:0007399 Nervous system development
GO:0048666 Neuron development
GO:0007409 Axonogenesis
The first column specifies the general biological process represented by the GO ter
and constitute the initial hypothesis for the functional basis of the disease. From fo
corresponding population and chip (FDR-adjusted p-values < 0.05) using the PBA ap
not significant, another direct descendant or ancestor GO term in the hierarchy wa
significant in the Spanish population but were consistently significant through theHowever, it is known that gene-based p-values are biased
towards longer genes and those within weak LD region.
Such genes have higher probability of encompassing more
independent SNPs that will increase the probability of dis-
playing significant p-values just by chance [33]. Although
this bias is less expectable in GO terms, because these are
composed by numerous genes with no a priori bias to-
wards any particular size, it is true that they exist GO
terms with a unexpectedly high number of large genes,
whose p-values can be biased [34]. In order to check po-
tential biases due to abnormally number of large genes in
GO terms we have plotted the distribution of gene sizes of
each significant class in Table 2 against the background
distribution of sizes and only three of them were slightly
bigger that the background distribution (see Additional file
2: Figure S1). Actually, three terms show a median size,
which is higher than the 3rd quartile of the distribution of
median gene sizes of all the GO terms (see Additional file
3: Figure S2). These GOs, however, are biologically related
to the disease and related to other GOs without this size
bias.
Figure 2 graphically summarizes a comprehensive map
of the biological functionalities associated to the disease.
GOs potentially affected by gene size bias are repre-
sented in a different color. As previously described, GO
modules related to signal transduction and its regulation
that include the parent regulation of signal transductionifferent populations analyzed with the Nsp and Sty chips,
Italy France Netherlands USA
Nsp Sty Nsp Sty Nsp Sty Nsp Sty
l transduction Y Y Y Y Y
on Y Y* Y Y* Y
Y Y Y Y Y
tion Y* Y* Y* Y*
ion Y Y Y*
Y* Y* Y* Y
g pathway Y
Y Y Y Y
Y Y Y* Y* Y*
Y* Y Y* Y Y* Y*
Y* Y Y Y Y
Y Y Y
Y Y Y Y
Y Y Y
Y Y Y
ms (columns 2 and 3) which were found significant in the Spanish population
urth column ahead a Y means that the GO term was significant in the
proach described in Methods. Y* means that although this particular term was
s significant. The last four files are GO terms (in italics) that were not initially
populations analyzed here.
Figure 2 Hierarchy of GO terms significantly associated to HSCR in the different populations analyzed with the Nsp and Sty chips,
separately (See Table 2). Red color means that the GO term, originally significant in the Spanish population [17] was also significant in all the
four Consortium populations in at least one of the chips (FDR-adjusted p-values < 0.05) using the PBA approach described in Methods. In Orange
color are represented those initially red color GO term in which there seems to be a potential bias due to the size of the genes composing the
GO. In green color there is a GO term, significant in the Spanish population and significant in only one population of the consortium (USA). The
blue color correspond GO terms that were not initially significant in the Spanish population but were consistently significant through the populations
analyzed here.
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small GTPase mediated signal transduction, GO:0051056;
regulation of Ras protein signal transduction, GO:0046578;
and regulation of Rho protein signal transduction,
GO:0035023), potentially affected by gene size bias,
and the regulatory terms small GTPase mediated signal
transduction (GO:0007264) and Ras protein signal
transduction (GO:0007265). However, enzyme linked
receptor protein signaling pathway (GO:0007167) was
only confirmed by the USA population, suggesting that
it is not a general mechanism of the disease but it
rather represents a population-specific peculiarity. Finally,
synaptic transmission (GO:0007268) a process whose
malfunction is licit to consider to have a role in the
disease, has also been validated in all the studied popula-
tions. On the other hand, cation transport (GO:0006812)
and, in particular, the descendent term calcium ion trans-
port (GO:0006816) are known to be altered in the disease.
Both terms have been validated in the four populations
analyzed. Finally, another functionality affected in all the
populations, related to the formation of functional enteric
cells, is cell-cell adhesion (GO:0016337). Of particular
interest is the discovery of a series of GO terms involvedin the generation of neurons that take part of the ENS,
such as nervous system development (GO:0007399) and
the descendant terms neuron development (GO:0048812)
and axonogenesis (GO:0007409). These terms did not
reach a significant p-value in the Spanish populations [17]
but, no doubt these functionalities can be considered as
part of the underlying mechanism of the disease.
Comparison of the gene functionalities associated to
HSCR observed between country sample populations
Apart from the validation of the core disease related
functionalities, the independent study of the functional
associations obtained by PBA of the 4 different country
populations of the ICHSCR rendered a considerable
number of GO terms.
Again, when individual country populations are inde-
pendently analysed two key processes become apparent:
signalling and neurogenesis. In fact, the GO terms synaptic
transmission, regulation of small GTPase mediated signal
transduction, Ras protein signal transduction and nervous
system development were significant in all the 5 analysed
populations. Moreover, it is clear from the figures
depicting the GO structure (Additional file 4: Figure S3
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of GO subcategories not shared by all the country
populations actually belong to three main branches:
nervous system development, signal transduction and
cell migration. Additional file 6: Table S2 and Additional
file 7: Table S3 show a total of 49 and 29 GO modules,
respectively, significantly associated to HSCR found in
the analysis individualized by population in any of the
two chips. Additional file 4: Figure S3 and Additional
file 5: Figure S4 show how all these modules are inter-
related among them. For example, terms like axonogenesis,
neuron development, neuron differentiation, generation of
neurons, are all descendants of neurogenesis, which is
itself, a descendant of nervous system development.
Cell-cell adhesion is also a parent term of many other
GO terms related with the formation of functional en-
teric cells. And there is also the case of other processes
whose malfunction is relevant in the disease, such as
synaptic transmission, the transport of several substances
(cation transport or phospholipid transport) or different
signalling-related functions, including the well-known
RAS/RHO intracellular signalling pathway.
In order to know if the GO module associations found
in each population were consistently a consequence of the
underlying associations of the same specific genes, we
compared the individual gene association values across all
country populations. A list with the SNPs mapping within
or in the neighborhood of genes ranked by association toFigure 3 Number of genes (blue line) and GO terms common to the f
The X axis (in logarithmic scale) represents the list of SNPs ranked by p-valu
common to the five populations, AGAP3, while SNPs in different genes wer
upper left square represents a detailed view of the first 100 ranked SNPs.HSCR (that is, the p-value of the TDT) was generated.
Figure 3 shows the genes common to the four Consor-
tium populations analyzed, plus the Spanish population
already studied [17]. Only AGAP3 and TUBA8 genes
are common to the five populations when the 400 SNPs
showing the highest association to HSCR are considered.
However, when the GO terms corresponding to the genes
are compared across populations, a remarkable coinci-
dence of affected functions occurs, as reflected in Table 2.
While in the case of genes we need to reach up to 200
SNPs to have more than one common gene, and up to
500 SNPs to have a third common gene (apart from
AGAP3 and TUBA8), when GO terms corresponding to
the genes that appear in the rank of the first 10 SNPs are
compared many coincidences are found. If we expand the
percentile, the coincidences in functionalities increase
enormously. All the coincident functionalities are related
again to signaling and ENS formation.
Therefore, our observations strongly suggest that
common functions affected in different populations are
not due to common genes but rather to different genes
of common functionality, which are affected in different
populations and cause similar phenotypic effects.
Network analysis
The lists of genes from both chips, ranked by association
to HSCR (according to SNP p-values obtained from the
corresponding TDTs), were scanned to find sub-networksour Consortium populations studied and the Spanish population.
e. For example, within the 50 first SNPs there is only one gene
e defining 11 GO terms common to the five populations analyzed. The
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ease [28]. The application of this network analysis to the
Nsp chip rendered a significant network (p-value = 0.027;
see Methods) within the first 27 most associated genes,
linking 19 of them. In the derivation of the network a
maximum of one external node linking these proteins
was allowed [28]. This significantly large sub-network
(Figure 4) significantly associated to the disease docu-
ments the basis of the complexity of this disorder.
Genes like GABBR2, GRIN2B and HTT associated to
synaptic transmission (GO:0007268), and the last one
also associated to ,central nervous system development
(GO:0007417) and neuron development (GO:0048666)
are among the 27 most associated genes, along with RET,
also in the list. Interestingly, genes connecting them and
included in the network significantly associated to the dis-
ease are: CRK, related with regulation of small GTPase
mediated signal transduction (GO:0051056), regulation of
Ras protein signal transduction (GO:0046578) and Ras
protein signal transduction (GO:0007265); GRB2, related
to Ras protein signal transduction (GO:0007265); ITGB1,
related to cell-cell adhesion (GO:0016337), cell migration
(GO:0016477), cell projection organization (GO:0030030)
and neuron development (GO:0048666); PLCG1, relatedFigure 4 Significant sub-network of 53 genes, allowing for one interm
chip. The network analysis [28] is carried out by using the functional analy
on the list of genes ranked by the p-values obtained upon the applicationto cell migration (GO:0016477); RPS27AP16, related
to synaptic transmission (GO:0007268), cell projection
organization (GO:0030030) and neuron development
(GO:0048666); SH3GL3 and TP53, related to central
nervous system development (GO:0007417). Again,
the main processes highlighted by the network analysis
are signalling and neurogenesis. Moreover, the close-
ness in the interactome of the HSCR genes to the genes
selected by the network analysis strongly supports the
relationship of the sub-network to the disease. The ap-
plication of this network analysis to the Sty chip results
in a significant network (p-value = 0.04; see Methods)
within the first 67 most associated genes. In the deriv-
ation of the network a maximum of one external node
linking these proteins was allowed [28] (see Additional
file 8: Figure S5). This larger network contains some of the
genes already linked in the Nsp network plus some others
and point exactly to the same affected functionalities.Extra-genic SNPs associated to HSCR that support the
functionalities found
Very recently the results of the ENCODE project have
been published, allowing to assign functionalities toediate gene, associated to HSCR (p-value = 0.027) in the Nsp
sis options (Set enrichment analysis/NetworkMiner) of Babelomics [26]
of a conventional TDT association test as implemented in PLINK [24].
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HSCR were found to map. Table 3 lists six extra-genic
SNPs with a nominal p-value < 10-5 obtained for each chip
analyzing all the trios together, for which some annota-
tion has been found. Thus, rs2435367, one of the SNPs
with a lowest p-value, is mapping in a DNAse hypersen-
sitivity region, typically related to gene expression, close
to the 5′ of RET. The SNP rs2505526 (p-value =
8.353×10-7), changes a transcription factor binding site
(TFBS), Pax-4, close to the RASGEF1A gene, related to
signal transduction (particularly the Ras pathway) and
ENS formation. The SNP rs16838932 (p-value = 4.459×10-
7) maps in a ultraconserved [35] region and it is difficult
to speculate any relation with the disease by itself or
through the closest gene, SLC39A10. The SNP
rs2659635 (p-value = 7.098×10-6) maps in a TFBS,
Foxj2, in an ultraconserved [35,36] genomic region. The
SNP rs4570660 (p-value = 7.744×10-6) maps in a DNAse
hypersensitive region and, within it, in the binding site
of the transcription factor Sox. Several Sox transcription
factors have been linked to neural crest evolution and de-
velopment [37]. Finally, rs12067906 (p-value = 9.584×10-6)
also maps in a DNAse hypersensitive region and onto two
TFBS (corresponding to Gfi1 and HLF, both related to
leukemia and several related pathologies). In addition, this
site is bound by the protein RAD21, involved in DNA
repair.
Discussion
Understanding the molecular and cellular processes
required for proper ENS development, and therefore the
corresponding defects that lead to HSCR, requires of the
knowledge of the functionalities affected by the genes
affected in the disease.
The PBA strategy has already been successfully applied
to the study of some traits such as coronary heart disease
risk [21], bipolar disorder [22], Crohn’s disease, hyperten-
sion, rheumatoid arthritis or diabetes among others [23].
These studies led to the identification of numerous path-
ways implicated in disease predisposition that would have
not been revealed using standard single-locus GWASTable 3 Extra-genic SNPs with a nominal p-value < 10-5 mapp
SNP Nominal p-value Adj. p-value (BH) Chip RefSeq gene
rs2435367 8.067×10-11 2.2083×10-06 Sty 5.9 kb 5′ of RE
rs2505526 8.353×10-07 0.01506847 Sty 7.5 kb 3′ of RASG
rs16838932 4.459×10-07 0.021091873 Nsp 421 kb 5′ of
SLC39A10
rs2659635 7.098×10-06 0,08204207 Sty 125 kb 5′ of
XRCC6BP1
rs4570660 7.744×10-06 0,08479448 Sty 65 kb 3′ of APO
rs12067906 9.584×10-06 0,09994469 Sty 96 kb 5′ of RG
In this case all the trios have been analysed together for each chip.statistical analysis criteria. Many of such pathways had
long been assumed to contain polymorphic genes that
lead to disease predisposition. The same conclusions
can be extracted from our results that reveal a clear asso-
ciation of GO terms connected to Ras signalling, widely
known as a pathway with a key role in ENS formation.
Regarding network analysis, it exploits the information
contained in the interactome with the idea that proteins
close in the interaction network will have a higher probabil-
ity of causing the same disease and constitutes a powerful
technique to detect gene-disease associations. Network
analysis has been successfully applied to discover genes in
different diseases, such as ataxias [38], Huntington disease
[39], schizophrenia [40] or Alzheimer’s [41]. Therefore we
considered it a really useful tool to be applied to the results
derived from the multinational GWAS in the context of
HSCR.
The recent description of HSCR-associated functional
modules in Spanish population [17] constitutes an excel-
lent initial functional hypothesis of the molecular mech-
anism of HSCR. We have used all the data available of
an international cohort of 162 trios of short-segment
Hirschsprung’s disease to carry out a multi-population
PBA study that validate the initial functional hypothesis.
Specifically, our study has led us to the confirmation of
a spectrum of different GOs related to the disease, being
of special interest those terms related to signal transduc-
tion, such as the ones connected to Ras signaling. The Ras
pathway is known to be one of the intracellular signaling
mediated by the RET receptor, and is involved in cell
survival and proliferation, both of them key biological
processes related to ENS formation [42]. Thus, in spite
of some apparent bias due to the size of the genes in
these GO terms, there are solid biological basis for the
involvement of such pathways in the disease. In
addition, previous studies have demonstrated that sig-
naling through the small Rho GTPases is also important
for colonization of the gut by enteric neural crest cells
and the concomitant growth of axons [42]. These results
strongly suggest that members of the Ras/Rho protein sig-
nal transduction or regulators may play a key role in theing in regions recently annotated in ENCODE [32]







BEC1 DNAse hypersensitivity Sox
S21 DNAse hypersensitivity RAD21 Gfi1, HLF
Fernández et al. Orphanet Journal of Rare Diseases 2013, 8:187 Page 9 of 11
http://www.ojrd.com/content/8/1/187pathogenesis of HSCR (Figure 2). Previous studies have
proposed some specific genes included in these GOs as
potential candidate genes for HSCR. For instance, it has
been shown an under-expression of the gene Arhgef3 in
mice deficient for RET when compared to wildtype mice,
which suggests its role in ENS formation. Interestingly,
the human homologue for this gene, ARHGEF3, maps to
3p14, a chromosomal region previously described as a sus-
ceptibility locus for HSCR [11,43], although to date its
candidature has not been further evaluated. On the other
hand, migration of enteric neural crest cells in the gut wall
during embryogenesis requires interactions between the
migrating neural crest cells and the extracellular matrix
(ECM) environment in different regions of the developing
gut. It implies a key role of cell migration during enteric
nervous system formation, and would support the associ-
ation to HSCR obtained for several related GO terms.
Therefore, all these associated GOs might provide poten-
tial candidate genes implicated in ENS formation and also
the pathogenesis of HSCR.
Our findings clearly show that, while the genes most
associated to HSCR are essentially different in the five
analyzed populations, gene modules with common func-
tions (GO terms) are the same. Thus, the comparative
analysis of the populations is revealing two important
facts: a) the GO biological processes significantly associ-
ated to the disease in the different series of the ICHSCR
strongly suggest that HSCR is caused in the different
populations by different particular genes belonging to the
same (or related) GO modules and b) such gene modules
carry out biological functions that can be assimilated
(using the GO hierarchy) to neurogenesis and signaling.
The network analysis also points to the same processes. In
other words, although we cannot exclude the existence of
some causative genes common to all the populations,
which still remain undetected, our results rather point to a
scenario in which HSCR is the result of different genes
causing approximately the same phenotypic effects in
different populations.
Additionally, the observations made with the extra-
genic SNPs suggest other possible disease mechanisms
for HSCR more related to regulation or DNA instability.
Some of these SNPs were markers of DNA hypersensi-
tivity regions in the neighborhood of genes such as RET
and, moreover, some of them directly point to TFBSs.
One of the SNPs was pointing out a region of binding of
a protein involved in DNA repair.
Conclusions
Independent evidences obtained from common gene
functionality and from physical protein-protein interac-
tions point to HSCR as a disease caused by variants in
genes belonging to some GO modules related to neuro-
genesis, in particular within the context of ENS formation,and signaling. Moreover, the analysis of extra-genic SNPs
in a functional context provided by the recent publication
of the results of the ENCODE project [32] provides add-
itional evidences in this direction. Interestingly, while the
gene associations were different across populations the af-
fected functionalities were always the same. This suggests
that the known difficulty in validating genes in different
populations [1,44,45] could be more a consequence of the
multigenic nature of the disease that a sampling problem.
In this scenario, the low percentage of the variance of
traits explained by individual genes [46] is an obvious con-
sequence of the fact that many complex diseases are the
result of different combinations of variants that occur in
different populations just by founder effects. Such different
sets of variants collectively cause a malfunction of parti-
cular functional modules, which constitute the ultimate
cause of the disease.
In summary, this comprehensive profile of functional
modules (GO) has proven to be a useful resource for fu-
ture developmental, biochemical and genetic studies. Our
findings indicate that this approach can help to identify
candidate genes for human disease susceptibility loci. Be-
yond technical considerations on the advantages of using
functional modules in the analysis of genotype data, the
biological pathways highlighted by our study provide
insights into the complex nature of HSCR, opens new
opportunities for validation of new disease genes and
may help in the definition of relatively tractable targets
for therapeutic intervention.
One known limitation of function-based approaches is
that variants not mapping within or close to genomic ele-
ments with a functional annotation remain unused in the
study. However, the recent availability of new functional
domains provided by the ENCODE consortium will allow
the extension of theses function-based studies (PBA, net-
work analysis, etc.) beyond the conventional studies based
on genes or known regulatory elements such as miRNAs.Additional files
Additional file 1: Table S1. Summary of the effects of the different
steps of the quality control.
Additional file 2: Figure S1. Gene length distribution of gene lengths
within GO terms. Significant GO terms from Table 2 are plotted in blue.
The background distribution of gene lengths in the rest of
non-significant GO terms is represented in yellow.
Additional file 3: Figure S2. Boxplots of gene length distribution of
gene lengths within GO terms. The first boxplot on the left, in yellow,
represents the distribution of genes in all the non-significant GO terms.
The rest of boxplots in blue correspond to the significant GO terms from
Table 2.
Additional file 4: Figure S3. Tree hierarchy depicting the relationships
between GO terms significantly associated to HSCR (FDR adjusted
p-value < 0.05) using the PBA [25] as implemented in Babelomics [26] in
the four country populations of the Consortium: French, Italian, Dutch
and USA for the Nsp chip. The results previously obtained for the Spanish
Fernández et al. Orphanet Journal of Rare Diseases 2013, 8:187 Page 10 of 11
http://www.ojrd.com/content/8/1/187population [17] have also been added. Significant terms have been
color-coded according the number of populations in which the GO terms
was found to be significant. The darkest values corresponds to GO terms
significant in five populations and the palest in only one population (see
Additional file 6: Table S2).
Additional file 5: Figure S4. Tree hierarchy depicting the relationships
between GO terms significantly associated to HSCR (FDR adjusted
p-value < 0.05) using the PBA [25] as implemented in Babelomics [26] in
the four country populations of the Consortium: French, Italian, Dutch
and USA for the Sty chip. The results previously obtained for the Spanish
population [17] have also been added. Significant terms have been
color-coded according the number of populations in which the GO terms
was found to be significant. The darkest values corresponds to GO terms
significant in two populations and the palest in only one population (see
Additional file 7: Table S3).
Additional file 6: Table S2. GO modules significantly associated to
HSCR (FDR adjusted p-value < 0.05) using the PBA [25] as implemented in
Babelomics [26] found in the analysis individualized by population in the
Nsp chip.
Additional file 7: Table S3. GO modules significantly associated to
HSCR (FDR adjusted p-value < 0.05) using the PBA [25] as implemented in
Babelomics [26] found in the analysis individualized by population in the
Sty chip.
Additional file 8: Figure S5. Significant sub-network of 65 genes,
allowing for one intermediate gene, associated to HSCR (p-value = 0.04)
in the Sty chip. The network analysis [28] is carried out by using the
functional analysis options (Set enrichment analysis/NetworkMiner) of
Babelomics [26] on the list of genes ranked by the p-values obtained
upon the application of a conventional TDT association test as
implemented in PLINK [24].
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